J 2023

Structural conservation of antibiotic interaction with ribosomes

PATERNOGA, Helge, Caillan CROWE-MCAULIFFE, Lars V BOCK, Timm O KOLLER, Martino MORICI et. al.

Basic information

Original name

Structural conservation of antibiotic interaction with ribosomes

Authors

PATERNOGA, Helge, Caillan CROWE-MCAULIFFE, Lars V BOCK, Timm O KOLLER, Martino MORICI, Bertrand BECKERT, Alexander G MYASNIKOV, Helmut GRUBMUELLER, Jiří NOVÁČEK (203 Czech Republic, belonging to the institution) and Daniel N WILSON (guarantor)

Edition

NATURE STRUCTURAL & MOLECULAR BIOLOGY, NEW YORK, NATURE PUBLISHING GROUP, 2023, 1545-9993

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 16.800 in 2022

RIV identification code

RIV/00216224:14740/23:00133510

Organization unit

Central European Institute of Technology

UT WoS

001043691200001

Keywords in English

ribosome; antibiotics; CryoEM; antibiotic–ribosome interactions; RNA-targeting therapies

Tags

Tags

International impact, Reviewed
Změněno: 27/10/2024 13:53, Ing. Martina Blahová

Abstract

V originále

Here the authors present the high-resolution structures of 17 antibiotics bound to Escherichia coli ribosomes, which may inform the development of new antibacterial agents. Their results unveil a conserved manner of antibiotic binding to the ribosome, including ordered water molecules.

Links

EF18_046/0015974, research and development project
Name: Modernizace České infrastruktury pro integrativní strukturní biologii
LM2023042, research and development project
Name: Česká infrastruktura pro integrativní strukturní biologii
Investor: Ministry of Education, Youth and Sports of the CR, CIISB - Czech Infrastructure for Integrative Structural Biology
871037, interní kód MU
Name: iNEXT-Discovery: Infrastructure for transnational access and discovery in integrated structural biology (Acronym: iNEXT- Discovery)
Investor: European Union, RI Research Infrastructures (Excellent Science)